Abstract
The authors administered 45-90 mg/day of tacrine to eight patients with tardive dyskinesia. After 2 weeks of treatment, there was a mean reduction in tardive dyskinesia scores of 43%. No improvement occurred when a placebo was used instead of tacrine.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Administration, Oral
-
Adult
-
Aminoacridines / therapeutic use*
-
Dyskinesia, Drug-Induced / drug therapy*
-
Dyskinesia, Drug-Induced / psychology
-
Female
-
Humans
-
Male
-
Middle Aged
-
Tacrine / administration & dosage
-
Tacrine / therapeutic use*